Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
RBC Bearings
RBC
$15.7B
| $6.32M | 0.01% |
+49,708
| New | +$6.68M |
|
1577
New Jersey Resources
NJR
$5.46B
| $6.31M | 0.01% |
126,794
-101,558
| -44% | -$4.83M |
|
1578
Sprouts Farmers Market
SFM
$8.01B
| $6.31M | 0.01% |
293,031
-132,507
| -31% | -$3.11M |
|
1579
CALL
ExxonMobil
XOM
$661B
| $6.31M | 0.01% |
+78,100
| New | +$5.95M |
|
|
I
1580
DELISTED
INTELSAT S. A.
I
| $6.29M | 0.01% |
401,700
+227,203
| +130% | +$4.82M |
|
1581
CALL
Teva Pharmaceuticals
TEVA
$44.4B
| $6.27M | 0.01% |
+400,000
| New | +$7.05M |
|
1582
Phibro Animal Health
PAHC
$1.46B
| $6.27M | 0.01% |
189,977
+28,167
| +17% | +$877K |
|
1583
Agree Realty
ADC
$9.24B
| $6.26M | 0.01% |
90,255
+83,908
| +1,322% | +$5.43M |
|
1584
PUT
eHealth
EHTH
$38.4M
| $6.23M | 0.01% |
100,000
| – | – |
|
1585
Watts Water Technologies
WTS
$12.4B
| $6.21M | 0.01% |
76,887
+24,599
| +47% | +$1.87M |
|
1586
CALL
CVS Health
CVS
$119B
| $6.2M | 0.01% |
115,000
+65,000
| +130% | +$4.01M |
|
1587
Intrepid Potash
IPI
$509M
| $6.19M | 0.01% |
163,349
+7,054
| +5% | +$245K |
|
1588
PetMed Express
PETS
$38.2M
| $6.19M | 0.01% |
271,612
+26,894
| +11% | +$606K |
|
1589
Middleby
MIDD
$5.15B
| $6.18M | 0.01% |
47,559
+3,556
| +8% | +$427K |
|
|
HIFR
1590
DELISTED
InfraREIT, Inc.
HIFR
| $6.18M | 0.01% |
294,582
-4,578
| -2% | -$96.9K |
|
1591
Oceaneering
OII
$4.97B
| $6.17M | 0.01% |
391,384
-50,093
| -11% | -$776K |
|
|
MYOK
1592
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $6.16M | 0.01% |
118,433
+68,397
| +137% | +$3.15M |
|
1593
Apogee Enterprises
APOG
$861M
| $6.14M | 0.01% |
163,715
+42,000
| +35% | +$1.46M |
|
1594
Enbridge
ENB
$109B
| $6.14M | 0.01% |
169,277
+134,599
| +388% | +$4.85M |
|
|
CPE
1595
DELISTED
Callon Petroleum Company
CPE
| $6.14M | 0.01% |
81,278
-75,319
| -48% | -$5.84M |
|
1596
Comtech Telecommunications
CMTL
$53M
| $6.13M | 0.01% |
264,183
+136,315
| +107% | +$3.37M |
|
1597
CALL
Labcorp
LH
$27.4B
| $6.12M | 0.01% |
+46,560
| New | +$5.74M |
|
|
XRN
1598
Chiron Real Estate Inc
XRN
$499M
| $6.11M | 0.01% |
124,521
+106,398
| +587% | +$5.24M |
|
|
RUTH
1599
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $6.11M | 0.01% |
238,925
+101,949
| +74% | +$2.49M |
|
|
LMNX
1600
DELISTED
Luminex Corp
LMNX
| $6.1M | 0.01% |
264,972
+239,755
| +951% | +$6.02M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.